Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CSL BEHRING via SQUIRE PATTON BOGGS
2013 · third_quarter · Q3
Preserving Access to Orphan Drugs Act; Orphan Drug Designation issues; NIH grant issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2013 · third_quarter · 3T
Source: Senate LDA
| KOOL SMILES |
| 1 |
| 2012 |
| QIAGEN, INC. | 1 | 2013 |
| RENAISSANCE LEARNING INC | 1 | 2011 |
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
Safeguarding America's Pharmaceuticals Act of 2013
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Safeguarding America's Pharmaceuticals Act of 2013
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Safeguarding America's Pharmaceuticals Act of 2013
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
Safeguarding America's Pharmaceuticals Act of 2013
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Ending Special Mail Privileges for Congress Act of 2014
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
Ending Special Mail Privileges for Congress Act of 2014
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 8, the American Taxpayer Relief Act; S. 214 Preserve Access to Affordale Generics Act
Preserve Access to Affordable Generics Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
Drug Supply Chain Security Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Drug Supply Chain Security Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Drug Supply Chain Security Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Drug Supply Chain Security Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
American Taxpayer Relief Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
American Taxpayer Relief Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 8, the American Taxpayer Relief Act; S. 214 Preserve Access to Affordale Generics Act
Federal Aviation Administration Extension Act of 2010
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
Federal Aviation Administration Extension Act of 2010
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
Federal Aviation Administration Extension Act of 2010
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Federal Aviation Administration Extension Act of 2010
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Federal Aviation Administration Extension Act of 2010
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Preserving Access to Orphan Drugs Act of 2011
Client: CSL BEHRING · Firm: SQUIRE PATTON BOGGS
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act Prescription Drug User Fee Act Reauthorization issues Orphan Drug Designation issues
Preserving Access to Orphan Drugs Act of 2011
Client: CSL BEHRING · Firm: SQUIRE PATTON BOGGS
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act; Orphan Drug Designation issues; NIH grant opportunities.
Preserving Access to Orphan Drugs Act of 2011
Client: CSL BEHRING · Firm: SQUIRE PATTON BOGGS
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act Prescription Drug User Fee Act Reauthorization issues Orphan Drug Designation issues NIH grant opportunities
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations; S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations; S.3187, the Food and Drug Administration Safety and Innovation Act.
Patient Safety and Drug Labeling Improvement Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, House FY 2013 Budget; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155).
Patient Safety and Drug Labeling Improvement Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155); H.R. 8, the American Taxpayer Relief Act; S. 27, the Preserve Access to Affordable Generics Act.
Patient Safety and Drug Labeling Improvement Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Patient Safety and Drug Labeling Improvement Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, the Food and Drug Administration Safety and Innovation Act; H.R. 5651, the Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, the House FY 2013 Budget; S 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Patient Safety and Drug Labeling Improvement Act
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations; S.3187, the Food and Drug Administration Safety and Innovation Act.
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
To suspend temporarily the duty on certain non-toric shaped polarized materials of 80 mm or less in diameter.
Client: WELCH ALLYN · Firm: SQUIRE PATTON BOGGS
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, the Food and Drug Administration Safety and Innovation Act; H.R. 5651, the Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, the House FY 2013 Budget; S 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155); H.R. 8, the American Taxpayer Relief Act; S. 27, the Preserve Access to Affordable Generics Act.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, House FY 2013 Budget; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155).
American Taxpayer Relief Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 8, the American Taxpayer Relief Act
American Taxpayer Relief Act of 2012
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: SQUIRE PATTON BOGGS
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155); H.R. 8, the American Taxpayer Relief Act; S. 27, the Preserve Access to Affordable Generics Act.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
To amend title XVI of the Social Security Act to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
Client: PRENEED INSURERS COALITION (AN INFORMAL COALITION) · Firm: SQUIRE PATTON BOGGS
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214, Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8, the Senate Budget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2013 · second_quarter · Q2
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2014 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act; Safeguarding America's Pharmaceuticals Act (H.R. 1919).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2013 · second_quarter · Q2
Preserving Access to Orphan Drugs Act; Orphan Drug Designation issues; NIH grant issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2013 · second_quarter · Q2
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 214 Preserve Access to Affordale Generics Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution; S. 959, Pharmaceutical Compounding Quality and Accountability Act; S. 957, Drug Supply Chain Security Act,H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 2186, Verifying Authority and Legality In Drug Compounding Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QIAGEN, INC. via SQUIRE PATTON BOGGS
2013 · second_quarter · RR
Issues regarding re-pricing of certain medical diagnostic tests for patients with cancer
WELCH ALLYN via SQUIRE PATTON BOGGS
2013 · first_quarter · Q1
Technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 523); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2013 · first_quarter · Q1
Preserving Access to Orphan Drugs Act; Orphan Drug Designation issues; NIH grant opportunities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2013 · first_quarter · Q1
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Implementation of S. 3187, Food and Drug Administration Safety and Innovation; H.R. 8, the American Taxpayer Relief Act; S. 214, Preserve Access to Affordable Generics Act; H.R. 933, Consolidated and Further Continuing Appropriations Act; H.Con.Res. 25, the House Budget Resolution; S.Con.Res 8,the Senate Buudget Resolution
Implementation of Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 8, the American Taxpayer Relief Act; S. 214 Preserve Access to Affordale Generics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2012 · fourth_quarter · 4A
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Guard, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2012 · fourth_quarter · Q4
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Guard, SENATE
KOOL SMILES via SQUIRE PATTON BOGGS
2012 · fourth_quarter · Q4
Issues related to multi-site, multi-state dental practices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2012 · fourth_quarter · Q4
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act; Orphan Drug Designation issues; NIH grant opportunities.
Filing targets: SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2012 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); H.R. 8, the American Taxpayer Relief Act
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155); H.R. 8, the American Taxpayer Relief Act; S. 27, the Preserve Access to Affordable Generics Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2012 · third_quarter · Q3
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations ; implementation of S.3187, the Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Guard, SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2012 · third_quarter · Q3
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act Prescription Drug User Fee Act Reauthorization issues Orphan Drug Designation issues NIH grant opportunities
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, Food and Drug Administration Safety and Innovation Act; H.R. 5651, Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, House FY 2013 Budget; S. 2295/H.R. 4384, Patient Safety and Generic Labeling Improvement Act; Sequestration Transparency Act of 2012 (P.L. 112-155).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2012 · second_quarter · Q2
S. 1423/H.R. 2672, the Preserving Access to Orphan Drugs Act Prescription Drug User Fee Act Reauthorization issues Orphan Drug Designation issues
Filing targets: SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); S. 3187, the Food and Drug Administration Safety and Innovation Act; H.R. 5651, the Food and Drug Administration Reform Act of 2012; H.Con.Res. 112, the House FY 2013 Budget; S 2295/H.R. 4384, the Patient Safety and Generic Labeling Improvement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2012 · second_quarter · Q2
NIH Alzheimer's and health technology research; Community Health Centers and School Health; Telemedicine; Implementation of Patient Protection & Affordable Care Act (H.R. 3590/P.L. 111-148) and Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The Protect Medical Innovation Act (H.R. 436); Budget Control Act (P.L. 112-25), FY2013 Budget, accountable care organizations; S.3187, the Food and Drug Administration Safety and Innovation Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Guard, Natl Institutes of Health (NIH), SENATE
CSL BEHRING via SQUIRE PATTON BOGGS
2012 · second_quarter · RR
Federal regulatory and legislative issues for plasma related products and specifically definitional issues under the orphan drug act.
MEMORY TRAINING CENTERS OF AMERICA via SQUIRE PATTON BOGGS
2012 · first_quarter · Q1
Medicare coding and payment for psychologists services to patients with cognitive impairment.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2012 · first_quarter · 1A
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
MEMORY TRAINING CENTERS OF AMERICA via SQUIRE PATTON BOGGS
2012 · first_quarter · RR
Issues with Medicare coding and reimbursement at Centers for Medicare & Medicaid Services (CMS).
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2012 · first_quarter · Q1
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements. S.2150/H.R.4149, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program.
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Budget Control Act (P.L. 112-25); Temporary Payroll Tax Cut Continuation Act of 2011 (P.L. 112-78).
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Prescription Drug User Fee Act (PDUFA) reauthorization (no introduced bill yet).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2011 · third_quarter · RA
corporate-owned life insurance
corporate-owned life insurance
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2011 · fourth_quarter · Q4
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2011 · fourth_quarter · Q4
Issues related to international sales; South Korea Free Trade Agreement.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via SQUIRE PATTON BOGGS
2011 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Budget Control Act (P.L. 112-25); Temporary Payroll Tax Cut Continuation Act of 2011 (P.L. 112-78).
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Prescription Drug User Fee Act (PDUFA) reauthorization (no introduced bill yet).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WELCH ALLYN via SQUIRE PATTON BOGGS
2011 · third_quarter · Q3
Issues related to international sales; South Korea Free Trade Agreement.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2011 · third_quarter · Q3
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
H.R.935/S.863, to amend Title XVI of the SSD to clarify that the value of certain funeral and burial arrangements are not to be considered available resources under the supplemental security income program. Issues related to state Medicaid policies around funeral and burial arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRENEED INSURERS COALITION (AN INFORMAL COALITION) via SQUIRE PATTON BOGGS
2011 · third_quarter · RA
corporate-owned life insurance
corporate-owned life insurance
RENAISSANCE LEARNING, INC. via SQUIRE PATTON BOGGS
2011 · second_quarter · Q2
No Child Left Behind Reauthorization, Response to Intervention Program, LEARN Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROJECT LEAD THE WAY (PLTW) via SQUIRE PATTON BOGGS
2011 · first_quarter · 1A
STEM Master Teachers Corps Act; Engineering Education for Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROJECT LEAD THE WAY (PLTW) via SQUIRE PATTON BOGGS
2011 · first_quarter · Q1
STEM Master Teachers Corps Act; Engineering Education for Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)